Fennec Pharmaceuticals Stock Price Patterns

FENC Stock  USD 8.42  0.22  2.68%   
At the present time, The RSI of Fennec Pharmaceuticals' share price is at 53. This usually indicates that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Fennec Pharmaceuticals, making its price go up or down.

Momentum 53

 Impartial

 
Oversold
 
Overbought
The successful prediction of Fennec Pharmaceuticals' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Fennec Pharmaceuticals, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Fennec Pharmaceuticals' stock price prediction:
EPS Estimate Next Quarter
0.2
EPS Estimate Current Year
(0.11)
EPS Estimate Next Year
0.628
Wall Street Target Price
15.2857
EPS Estimate Current Quarter
(0.03)
Using Fennec Pharmaceuticals hype-based prediction, you can estimate the value of Fennec Pharmaceuticals from the perspective of Fennec Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Fennec Pharmaceuticals using Fennec Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Fennec using crowd psychology based on the activity and movement of Fennec Pharmaceuticals' stock price.

Fennec Pharmaceuticals Implied Volatility

    
  1.51  
Fennec Pharmaceuticals' implied volatility exposes the market's sentiment of Fennec Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Fennec Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Fennec Pharmaceuticals stock will not fluctuate a lot when Fennec Pharmaceuticals' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Fennec Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Fennec because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Fennec Pharmaceuticals after-hype prediction price

    
  USD 8.42  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.

Prediction based on Rule 16 of the current Fennec contract

Based on the Rule 16, the options market is currently suggesting that Fennec Pharmaceuticals will have an average daily up or down price movement of about 0.0944% per day over the life of the 2026-05-15 option contract. With Fennec Pharmaceuticals trading at USD 8.42, that is roughly USD 0.007946 . If you think that the market is fully incorporating Fennec Pharmaceuticals' daily price movement you should consider acquiring Fennec Pharmaceuticals options at the current volatility level of 1.51%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Fennec Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
For information on how to trade Fennec Stock refer to our How to Trade Fennec Stock guide.
Intrinsic
Valuation
LowRealHigh
7.179.7612.35
Details
5 Analysts
Consensus
LowTargetHigh
13.9115.2916.97
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.03-0.03-0.03
Details

Fennec Pharmaceuticals After-Hype Price Density Analysis

As far as predicting the price of Fennec Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Fennec Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Fennec Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Fennec Pharmaceuticals Estimiated After-Hype Price Volatility

In the context of predicting Fennec Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Fennec Pharmaceuticals' historical news coverage. Fennec Pharmaceuticals' after-hype downside and upside margins for the prediction period are 5.83 and 11.01, respectively. We have considered Fennec Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
8.42
8.42
After-hype Price
11.01
Upside
Fennec Pharmaceuticals is somewhat reliable at this time. Analysis and calculation of next after-hype price of Fennec Pharmaceuticals is based on 3 months time horizon.

Fennec Pharmaceuticals Stock Price Outlook Analysis

Have you ever been surprised when a price of a Company such as Fennec Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Fennec Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Fennec Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.03 
2.59
 0.00  
 0.00  
6 Events / Month
7 Events / Month
In about 6 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
8.42
8.42
0.00 
2,590  
Notes

Fennec Pharmaceuticals Hype Timeline

Fennec Pharmaceuticals is currently traded for 8.42. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Fennec is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is estimated to be very small, whereas the daily expected return is currently at -0.03%. %. The volatility of related hype on Fennec Pharmaceuticals is about 1918.52%, with the expected price after the next announcement by competition of 8.42. About 13.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.26. Fennec Pharmaceuticals had not issued any dividends in recent years. The entity had 1:3 split on the 9th of September 2014. Given the investment horizon of 90 days the next estimated press release will be in about 6 days.
Check out Fennec Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
For information on how to trade Fennec Stock refer to our How to Trade Fennec Stock guide.

Fennec Pharmaceuticals Related Hype Analysis

Having access to credible news sources related to Fennec Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Fennec Pharmaceuticals' future price movements. Getting to know how Fennec Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Fennec Pharmaceuticals may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
EPRXEupraxia Pharmaceuticals Common 1.18 6 per month 2.57  0.11  6.71 (4.46) 24.61 
AARDAardvark Therapeutics Common(0.05)26 per month 4.42  0.05  9.35 (8.66) 38.95 
RNACCartesian Therapeutics(0.53)7 per month 0.00 (0.03) 7.26 (8.08) 28.90 
PRLDPrelude Therapeutics 0.03 8 per month 6.65  0.14  13.57 (12.90) 36.35 
CRBUCaribou Biosciences 0.1 8 per month 0.00 (0.09) 6.86 (6.41) 20.16 
AVTXAvalo Therapeutics 0.34 10 per month 4.42 (0.01) 6.93 (6.79) 23.40 
ENTAEnanta Pharmaceuticals 0.47 3 per month 2.73  0.08  5.67 (3.78) 15.79 
BDTXBlack Diamond Therapeutics(0.07)6 per month 0.00 (0.22) 4.71 (8.49) 27.99 
NAUTNautilus Biotechnology 0.04 6 per month 4.32  0.09  9.29 (7.62) 28.35 
OBIOOrchestra BioMed Holdings(0.16)8 per month 4.22  0.01  10.17 (6.43) 22.05 

Fennec Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Fennec price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Fennec using various technical indicators. When you analyze Fennec charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Fennec Pharmaceuticals Predictive Indicators

The successful prediction of Fennec Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Fennec Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Fennec Pharmaceuticals based on analysis of Fennec Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Fennec Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Fennec Pharmaceuticals's related companies.
 2023 2024 2025 2026 (projected)
Interest Debt Per Share1.290.860.770.81
Revenue Per Share0.81.741.571.65

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Complementary Tools for Fennec Stock analysis

When running Fennec Pharmaceuticals' price analysis, check to measure Fennec Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fennec Pharmaceuticals is operating at the current time. Most of Fennec Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Fennec Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fennec Pharmaceuticals' price. Additionally, you may evaluate how the addition of Fennec Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges